The Psychedelics and Cannabis Work Group was formed in 2023 to explore health (therapeutic and toxicological), regulatory, and social issues related to the broadening decriminalization and clinical use of psychedelic compounds and cannabis, with an emphasis on advocating for scientific input on safety-related issues. Changes to the use and regulation of these compounds, some of which have medicinal histories, raise public and occupational health concerns.
Current and upcoming activities include:
- Networking events for interested attendees at the Society of Toxicology annual meeting as well as development of scientific sessions for the SOT, Environmental Mutagenesis and Genomics, and American Academy of Clinical Toxicology meetings in 2024, 2025, and proposed for 2026.
- Development of a special issue for Current Opinion in Toxicology, Psychedelics and Cannabis: Toxicological Perspectives and Public Health Challenges, target publication date of late 2025.
- A Listserv of scientists interested in psychedelics and cannabis research.
The Psychedelics and Cannabis Work Group collaborates with other SLC Work Groups. Work Group participation is open to all SLC representatives.